ALDH3A1 acts as a prognostic biomarker and inhibits the epithelial mesenchymal transition of oral squamous cell carcinoma through IL-6/STAT3 signaling pathway. Here, ALDH3A1 is linked to oral cavity squamous cell carcinoma.